scholarly journals Immune Thrombocytopenic Purpura as Initial Presentation of Paediatric SLE: A Case Report

2020 ◽  
Vol 59 (233) ◽  
Author(s):  
Anjila Ghimire

The systemic lupus erythematosus (SLE) is a connective tissue disorder with variable presentationsin children. The usual presentation includes arthritis, malar rash, nephritis, hemolytic anemia, andfever. Isolated hematologic abnormality as the only presentation of SLE is rare. Here is a case reportof a female child presented to us with superficial and mucosal bleeding with isolated low plateletcount and anemia in proportion to blood loss. When platelet count didn’t go up despite appropriatetreatment in lines of ITP, further investigations were done, diagnosis of SLE was established, andmanagement was done accordingly.

2021 ◽  
pp. 1-5
Author(s):  
Maya Kornowski Cohen ◽  
Liron Sheena ◽  
Yair Shafir ◽  
Vered Yahalom ◽  
Anat Gafter-Gvili ◽  
...  

SARS-CoV-2 has been reported as a possible triggering factor for the development of several autoimmune diseases and inflammatory dysregulation. Here, we present a case report of a woman with a history of systemic lupus erythematosus and antiphospholipid syndrome, presenting with concurrent COVID-19 infection and immune thrombotic thrombocytopenic purpura (TTP). The patient was treated with plasma exchange, steroids, and caplacizumab with initial good response to therapy. The course of both TTP and COVID-19 disease was mild. However, after ADAMTS-13 activity was normalized, the patient experienced an early unexpected TTP relapse manifested by intravascular hemolysis with stable platelet counts requiring further treatment. Only 3 cases of COVID-19 associated TTP were reported in the literature thus far. We summarize the literature and suggest that COVID-19 could act as a trigger for TTP, with good outcomes if recognized and treated early.


2004 ◽  
Vol 31 (1) ◽  
pp. 17-20 ◽  
Author(s):  
Birol Guvenc ◽  
Cagatay Unsal ◽  
Emel Gurkan ◽  
Abdullah Canataroğlu ◽  
Bunyamin Saritas ◽  
...  

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 4685-4685
Author(s):  
Yang He ◽  
Weiwen Yang ◽  
Changgeng Ruan

Abstract Abstract 4685 Background: The occurrence of thrombotic thrombocytopenic purpura (TTP) in patients with systemic lupus erythematosus (SLE) is rare TTP frequence. In pregnancy women is increased. TTP with simultaneous SLE, and antiphospholipid syndrome (APS) occurring in the same patient is extremely rare. Case report: We described a 41-year-old Chinese female with TTP in her third trimester (33+4 gestational weeks) of pregnancy who suffered from SLE. and APS at the same time. The clinical features and positive laboratory abnormalities included fever, repeated abortion in first trimester, palpitation, dyspnea, orthopnea, hypertension (180/113mmHg), proteinuria, renal dysfunction, thrombocytopenia (platelets count 12×109/L), hemolytic anemia (Hb 67g/L), positive Coombs test, positive lupus test, positive antinuclear antibody, anti-Sm antibody, anti-insulin antibody, anti-ENA antibody and anti-RNP antibody. The level of plasma ADAMTS13 activity was below 5%, and ADAMTS13 inhibitor was present in the patient's plasma. This patient was treated with a combination of corticosteroids and plasma infusion and plasmapheresis. At 33+5 weeks of gestation she delivered a healthy infant via cesarean section. The patient improved quickly with these therapies. Conclusion: This is a rare TTP case with simultaneous SLE, APS and preeclampsia. Her overlaping clinical manifestations and laboratory abnormalities made the diagnosis very difficult. These data indicate that plasma therapy and corticosteroids can improve the prognosis of TTP associated with SLE and APS. In addition, the termination of pregnancy may be also helpful for controlling the development of the disease. Disclosures: No relevant conflicts of interest to declare.


2021 ◽  
pp. 366-371
Author(s):  
Kamel El-Reshaid ◽  
Shaikha Al-Bader ◽  
Hossameldin Tawfik Sallam

Skin is involved in 80% of systemic lupus erythematosus (SLE) and the second most affected after joint disease. Lupus-specific lesions include (a) acute ones viz. malar rash (80%), (b) subacute ones viz. photosensitive maculopapular dermatitis (50%), and (c) chronic ones viz. discoid rash. The lupus nonspecific lesions include; (a) nonscarring alopecia (86.67%), oral ulcers (56.67%), vasculitic lesions (33.34%), bullous lesions (10%), and Raynaud’s phenomenon (6.67%). In this case report, we describe a patient with SLE and antiphospholipid antibodies that had developed a transient facial form of Raynaud’s phenomenon that was not associated with disease activity and digital changes. Its association with SLE is discussed.


Sign in / Sign up

Export Citation Format

Share Document